BSE:512217

Stock Analysis Report

Executive Summary

Prism Medico and Pharmacy Limited engages in the wholesale and retail of straw, fodder, and other animal/poultry feed in India.


Snowflake Analysis

Flawless balance sheet and overvalued.

Share Price & News

How has Prism Medico and Pharmacy's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 512217's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

0.4%

512217

14.8%

IN Food

8.9%

IN Market


1 Year Return

-66.7%

512217

-3.8%

IN Food

-30.6%

IN Market

Return vs Industry: 512217 underperformed the Indian Food industry which returned -3.8% over the past year.

Return vs Market: 512217 underperformed the Indian Market which returned -30.6% over the past year.


Shareholder returns

512217IndustryMarket
7 Day0.4%14.8%8.9%
30 Day-24.5%-13.9%-24.8%
90 Day-38.8%-12.3%-29.4%
1 Year-66.7%-66.7%-2.4%-3.8%-29.2%-30.6%
3 Year-68.1%-68.1%43.8%39.4%-17.0%-21.5%
5 Year-34.3%-34.3%84.2%75.2%-5.4%-10.4%

Price Volatility Vs. Market

How volatile is Prism Medico and Pharmacy's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Prism Medico and Pharmacy undervalued compared to its fair value and its price relative to the market?

0.59x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate 512217's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate 512217's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: 512217 is unprofitable, so we can't compare its PE Ratio to the Food industry average.

PE vs Market: 512217 is unprofitable, so we can't compare its PE Ratio to the Indian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 512217's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 512217 is good value based on its PB Ratio (0.6x) compared to the IN Food industry average (0.7x).


Next Steps

Future Growth

How is Prism Medico and Pharmacy forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

21.1%

Forecasted Food, Beverage & Tobacco industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Prism Medico and Pharmacy has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Prism Medico and Pharmacy performed over the past 5 years?

-7.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 512217 is currently unprofitable.

Growing Profit Margin: 512217 is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: 512217 is unprofitable, and losses have increased over the past 5 years at a rate of -7% per year.

Accelerating Growth: Unable to compare 512217's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 512217 is unprofitable, making it difficult to compare its past year earnings growth to the Food industry (20.6%).


Return on Equity

High ROE: 512217 has a negative Return on Equity (-3.25%), as it is currently unprofitable.


Next Steps

Financial Health

How is Prism Medico and Pharmacy's financial position?


Financial Position Analysis

Short Term Liabilities: 512217's short term assets (₹145.9M) exceed its short term liabilities (₹116.9M).

Long Term Liabilities: 512217's short term assets (₹145.9M) exceed its long term liabilities (₹311.0K).


Debt to Equity History and Analysis

Debt Level: 512217 is debt free.

Reducing Debt: 512217 has no debt compared to 5 years ago when its debt to equity ratio was 0.01%.


Balance Sheet

Inventory Level: 512217 has a high level of physical assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if 512217's debt is covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 512217 has been profitable on average in the past, therefore cash runway is not a concern.

Forecast Cash Runway: Insufficient data to determine if 512217 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is Prism Medico and Pharmacy's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate 512217's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate 512217's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 512217's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 512217's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 512217's dividend in 3 years as they are not forecast to pay a notable one for the Indian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.0yrs

Average board tenure


CEO

Prism Medico and Pharmacy has no CEO, or we have no data on them.


Board Members

NamePositionTenureCompensationOwnership
Sehejbir Bhatia
Executive Director2.25yrs₹30.00kno data
Sudhanshu Siivastav
Executive Director0.42yrno datano data
Charu Pareek
Independent Director4.83yrs₹3.00kno data
Rishipal Panwar
Independent Director2yrs₹3.00kno data
Jimit Trivedi
Non Executive Director0.42yrno datano data

2.0yrs

Average Tenure

Experienced Board: 512217's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Prism Medico and Pharmacy Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Prism Medico and Pharmacy Limited
  • Ticker: 512217
  • Exchange: BSE
  • Founded: 2002
  • Industry: Agricultural Products
  • Sector: Food, Beverage & Tobacco
  • Market Cap: ₹72.155m
  • Shares outstanding: 6.06m
  • Website: https://www.prismmedico.com

Number of Employees


Location

  • Prism Medico and Pharmacy Limited
  • D-118, Industrial Area
  • Phase VII
  • Mohali
  • Punjab
  • 160055
  • India

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
512217BSE (Mumbai Stock Exchange)YesEquity SharesININRApr 2005

Biography

Prism Medico and Pharmacy Limited engages in the wholesale and retail of straw, fodder, and other animal/poultry feed in India. The company was formerly known as Woolite Mercantile Company Limited and changed its name to Prism Medico and Pharmacy Limited in January 2012. Prism Medico and Pharmacy Limited was incorporated in 2002 and is based in Mohali, India. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/03/31 12:37
End of Day Share Price2020/03/31 00:00
Earnings2019/12/31
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.